Last C$14.62 CAD
Change Today -0.13 / -0.88%
Volume 1.3K
NDQ On Other Exchanges
Symbol
Exchange
Toronto
NASDAQ GM
Frankfurt
As of 3:59 PM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

novadaq technologies inc (NDQ) Snapshot

Open
C$14.91
Previous Close
C$14.75
Day High
C$14.91
Day Low
C$14.62
52 Week High
04/3/14 - C$27.39
52 Week Low
08/13/14 - C$13.00
Market Cap
811.0M
Average Volume 10 Days
1.2K
EPS TTM
C$-0.68
Shares Outstanding
55.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NOVADAQ TECHNOLOGIES INC (NDQ)

Related News

No related news articles were found.

novadaq technologies inc (NDQ) Related Businessweek News

No Related Businessweek News Found

novadaq technologies inc (NDQ) Details

Novadaq Technologies Inc. develops, manufactures, and commercializes fluorescence imaging products and therapeutic devices for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The company’s proprietary imaging platform is used to visualize blood vessels, nerves, and the lymphatic system during surgical procedures. Its SPY and SPY Elite systems are used in coronary artery bypass graft surgery, cardiovascular surgery, plastic surgery, reconstructive surgery, microsurgery, organ transplant, and gastrointestinal surgery. The company’s LUNA fluorescence angiography system enables physicians treating chronic wounds for the treatment of diabetic foot ulcers, pressure sores, and other serious chronic non-healing wounds. Its FIREFLY imaging system is used for robotic surgery; and PINPOINT endoscopic fluorescence imaging system is used for traditional endoscope and to obtain fluorescence images on demand or in a simultaneous imaging mode during minimally invasive surgery. The company also offers SPY analysis toolkit, a post-processing software that allows surgeons to enhance and apply objective analysis tools to SPY Elite and LUNA images; CO2 heart laser systems for transmyocardial revascularization; and Trapper surgical imaging system. It has operations primarily in the United States and Japan. Novadaq Technologies Inc. was founded in 2000 and is headquartered in Mississauga, Canada.

Founded in 2000

novadaq technologies inc (NDQ) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $364.1K
Chief Financial Officer
Total Annual Compensation: $174.8K
Vice President of Operations
Total Annual Compensation: $174.8K
Senior Vice President and General Manager
Total Annual Compensation: $218.5K
Senior Vice President of Marketing
Total Annual Compensation: $182.5K
Compensation as of Fiscal Year 2013.

novadaq technologies inc (NDQ) Key Developments

Novadaq(R) Technologies Inc. Announces Appointment of Robert S. White to its Board of Directors

Novadaq(R) Technologies Inc. announced that Robert "Bob" S. White has been appointed to the company's Board of Directors. Mr. White was most recently the President and Chief Executive Officer of TYRX.

Novadaq Technologies Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Novadaq Technologies Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported total revenues of $11,152,156 compared to $8,097,949 a year ago. Loss from operations was $4,572,313 compared to $2,277,595 a year ago. Income before income taxes was $6,280,951 compared to loss before income taxes of $9,712,916 a year ago. Net income and comprehensive income for the period was $6,280,951 or $0.08 per diluted share compared to net loss and comprehensive loss for the period of $9,737,916 or $0.21 per diluted share a year ago. Cash used in operating activities was $7,614,364 compared to $3,511,544 a year ago. Purchase of property and equipment was $2,025,681 compared to $1,886,301 a year ago. Purchase of intangible assets including transaction costs was $6,368,753. For the six months, the company reported total revenues of $21,450,378 compared to $15,376,392 a year ago. Loss from operations was $8,833,077 compared to $2,927,487 a year ago. Loss before income taxes was $9,830,351 compared to $12,625,196 a year ago. Net loss and comprehensive loss for the period was $9,830,351 or $0.18 per diluted share compared to $12,670,196 or $0.29 per diluted share a year ago. Cash used in operating activities was $11,339,114 compared to $4,268,812 a year ago. Purchase of property and equipment was $4,316,388 compared to $3,138,217 a year ago. Purchase of intangible assets including transaction costs was $6,368,753.

Novadaq Technologies Inc. to Report Q2, 2014 Results on Aug 05, 2014

Novadaq Technologies Inc. announced that they will report Q2, 2014 results Pre-Market on Aug 05, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NDQ:CN C$14.62 CAD -0.13

NDQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CryoLife Inc $9.80 USD -0.08
View Industry Companies
 

Industry Analysis

NDQ

Industry Average

Valuation NDQ Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 18.1x
Price/Book 4.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 14.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVADAQ TECHNOLOGIES INC, please visit www.novadaq.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.